Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Kidney International|January 4, 2026
Disentangling disease heterogeneity in C3 glomerulopathies: a slippery roadCaroline Duineveld, Jack F M WetzelsClinical Toxicology (Philadelphia, Pa.)|January 26, 2012
Acute intoxications: differences in management between six Dutch hospitalsCaroline Duineveld, Maurice Vroegop, Lori Schouren, et al.Pediatric Nephrology (Berlin, Germany)|January 16, 2019
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive useKioa L Wijnsma, Caroline Duineveld, Jack F M Wetzels, et al.Pediatric Nephrology (Berlin, Germany)|November 8, 2018
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive useKioa L Wijnsma, Caroline Duineveld, Jack F M Wetzels, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 20, 2017
Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case SeriesCaroline Duineveld, Jacobien C Verhave, Stefan P Berger, et al.Pediatric Nephrology (Berlin, Germany)|May 25, 2020
Treatment-resistant nephrotic syndrome in dense deposit disease: complement-mediated glomerular capillary wall injury?Caroline Duineveld, Eric J Steenbergen, Andrew S Bomback, et al.Clinical Kidney Journal|October 11, 2021
Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawalCaroline Duineveld, Romy Bouwmeester, Joost W van der Heijden, et al.Kidney International Reports|February 5, 2024
Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot StudyCaroline Duineveld, Romy N Bouwmeester, Lambertus P W J van den Heuvel, et al.Transplantation|July 25, 2024
Kidney Transplantation in Patients With aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue TherapyCaroline Duineveld, Emily K Glover, Romy N Bouwmeester, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndromeKioa L Wijnsma, Caroline Duineveld, Elena B Volokhina, et al.Pageof 2